Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Mikram, Jafri"'
Publikováno v:
Journal of Clinical Gastroenterology. 57:39-47
Opioid-induced constipation (OIC) is a common condition in older adults who may not be responsive to traditional laxative therapy. OIC is defined as new or worsening constipation symptoms that occur with initiation of or altering the dose of opioid a
Publikováno v:
Clinical Interventions in Aging. 14:609-614
Background According to Surveillance, Epidemiology and End Results (SEER) database, colorectal cancer (CRC) is the fourth most common type of cancer and second highest in cancer-related death after lung cancer. The SEER database is geographically lim
Publikováno v:
Journal of Gastrointestinal Oncology. 10:12-18
Background: The US Preventive Services Task Force of Colorectal Cancer (USPSTF) recommends against continuing screening for colorectal cancer (CRC) past 75 years in adequately screened individuals. Survival and staging data for CRC that compares elde
Autor:
Mikram, Jafri, Amit, Sachdev, Javed, Sadiq, David, Lee, Ting, Taur, Adam, Goodman, Frank, Gress
Publikováno v:
JOP : Journal of the pancreas. 18(2)
Endotherapy is a treatment modality that can be used to manage the pain associated with chronic pancreatitis. The aim of this systematic review and meta-analysis is to evaluate the efficacy of endotherapy in the management of pain associated with chr
Publikováno v:
JOP : Journal of the pancreas. 17(5)
Endoscopic ultrasound guided elastography is an imaging modality that can be used to evaluate tissue stiffness and to assess solid pancreatic lesions. It can also assist in optimizing the diagnostic yield of endoscopic ultrasound guided fine needle a
Publikováno v:
American Journal of Gastroenterology. 113:S148-S149
Publikováno v:
Gastrointestinal Endoscopy. 85:AB359-AB360
Publikováno v:
American Journal of Gastroenterology. 112:S120
Publikováno v:
World Journal of Clinical Oncology
Epidermal growth factor receptor (EGFR) has been an attractive target for treatment of epithelial cancers, including colorectal cancer (CRC). Evidence from clinical trials indicates that cetuximab and panitumumab (anti-EGFR monoclonal antibodies) hav
Autor:
Frank G. Gress, Lauren G. Khanna, John M. Poneros, Mikram Jafri, Tamas A. Gonda, Ashish R. Shah, Amrita Sethi
Publikováno v:
Gastrointestinal Endoscopy. 81:AB401